1. Home
  2. CAMT vs MIRM Comparison

CAMT vs MIRM Comparison

Compare CAMT & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAMT
  • MIRM
  • Stock Information
  • Founded
  • CAMT 1987
  • MIRM 2018
  • Country
  • CAMT Israel
  • MIRM United States
  • Employees
  • CAMT N/A
  • MIRM N/A
  • Industry
  • CAMT Electronic Components
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAMT Technology
  • MIRM Health Care
  • Exchange
  • CAMT Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • CAMT 3.8B
  • MIRM 3.8B
  • IPO Year
  • CAMT 2000
  • MIRM 2019
  • Fundamental
  • Price
  • CAMT $120.18
  • MIRM $67.97
  • Analyst Decision
  • CAMT Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • CAMT 11
  • MIRM 12
  • Target Price
  • CAMT $108.00
  • MIRM $81.58
  • AVG Volume (30 Days)
  • CAMT 469.5K
  • MIRM 492.9K
  • Earning Date
  • CAMT 11-10-2025
  • MIRM 11-04-2025
  • Dividend Yield
  • CAMT 1.10%
  • MIRM N/A
  • EPS Growth
  • CAMT 38.64
  • MIRM N/A
  • EPS
  • CAMT 2.73
  • MIRM N/A
  • Revenue
  • CAMT $471,588,000.00
  • MIRM $471,794,000.00
  • Revenue This Year
  • CAMT $17.39
  • MIRM $53.14
  • Revenue Next Year
  • CAMT $8.22
  • MIRM $19.83
  • P/E Ratio
  • CAMT $45.29
  • MIRM N/A
  • Revenue Growth
  • CAMT 27.88
  • MIRM 53.66
  • 52 Week Low
  • CAMT $47.41
  • MIRM $36.88
  • 52 Week High
  • CAMT $129.41
  • MIRM $78.55
  • Technical
  • Relative Strength Index (RSI)
  • CAMT 54.66
  • MIRM 40.15
  • Support Level
  • CAMT $116.86
  • MIRM $68.71
  • Resistance Level
  • CAMT $125.53
  • MIRM $74.00
  • Average True Range (ATR)
  • CAMT 4.67
  • MIRM 2.95
  • MACD
  • CAMT -0.96
  • MIRM -0.28
  • Stochastic Oscillator
  • CAMT 48.92
  • MIRM 22.68

About CAMT Camtek Ltd.

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: